2024
JAMA, (2024).333 1 10.1001/jama.2024.22343.
2024
The Lancet. Infectious diseases, (2024).25 4 10.1016/S1473-3099(24)00580-2.
Parasite clearance and protection from plasmodium falciparum infection: clinical results from a two-arm, parallel, double-blinded, placebo-controlled, randomized trial of presumptive sulfadoxine-pyrimethamine versus artesunate monotherapy among asympto...
2024
(2024).(5); 7303 110
The effect of additional doses of sulfadoxine-pyrimethamine administered as perennial malaria chemoprevention on hemoglobin levels among children in a malaria endemic area of Cameroon.
2024
(2024).8019 110 (5)
The effect of intermittent preventive treatment of malaria in pregnancy (IPTp) on the maternal intestinal microbiome and its relationship with fetal growth.
2024
(2024).(5); 6457 110
The utility of qPCR estimation of parasite density in evaluating the effect of sulfadoxine-pyrimethamine as perennial malaria chemoprevention.
2024
(2024).(5); 7161 110
Bacterial vaginosis is associated with increased risk of placental malaria.
2024
(2024).(5) 7233 110
Parasite clearance and protection from plasmodium falciparum infection: clinical results from a three-arm, parallel, double-blinded, placebo-controlled, randomized trial of presumptive sulfadoxine-pyrimethamine versus sulfadoxine-pyrimethamine plus amo...
2024
(2024).(5); 7189 110
Effect of intermittent preventive treatment of malaria in pregnancy on vaginal microbiota, host immune response and pregnancy outcomes: a case-control study from the ASPIRE trial in Zambia.
2024
(2024).(5); 6834 110
Maintaining power in malaria cluster randomized trials using strategies/designs to mitigate the impact of heterogeneity.
2024
(2024).
